Medgenics, Inc.

Medgenics, Inc.

Sector: Pharmaceutical Preparations Region: PA, United States

: | NYSE MKT: MDGN | NYSE MKT: MDGN.WT | London Stock Exchange: MEDU | OTC Markets: MDGWW | London Stock Exchange: MEDG

Similar to: AstraZeneca Plc, United-Guardian, Inc., Mast Therapeutics, Inc.

Medgenics, Inc. is a medical technology and therapeutics company, which develops protein therapeutics medical therapies. It develops Biopump technology which is used for the treatment of a range of chronic diseases and its product pipeline includes Epodure, Infradure and Hemodure The Company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in San Francisco, CA.

News & Analysis

You may also be interested in: